Trial Profile
Age and gender study investigating the safety, tolerance and pharmacokinetics of BC-3781.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Apr 2011
Price :
$35
*
At a glance
- Drugs Lefamulin (Primary)
- Indications Bacterial infections; Community-acquired pneumonia; Skin and soft tissue infections
- Focus Adverse reactions